Venker Eric

Venker Eric is listed in filings as President & Immunovant CEO at Roivant Sciences Ltd.. This profile follows SEC Form 4 activity through May 22, 2026, including sale activity. Recent filings connect the profile to Roivant Sciences Ltd. (ROIV) and Immunovant, Inc. (IMVT). The current snapshot covers public activity from Nov 24, 2025 to May 22, 2026. Reported amounts are shown as $142.9K to $770.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.